Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777734
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2022-04-29
First Post:
2021-02-26
Brief Title:
Efgartigimod Expanded Access for Generalized Myasthenia Gravis
Sponsor:
Organization:
argenx